Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | Importance of occupational therapy for patients in early clinical trials

Alastair Greystoke • 30 Jan 2020
BTOG 2020
General Lung Cancer

Alastair Greystoke, MBChB, MSc, PhD, MRCP, Northern Institute for Cancer Research, Newcastle University, Newcastle, UK, outlines the need for occupational therapists during early clinical trials in order to maintain patient’s fitness during their wait for new therapy. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

More from Alastair Greystoke

6:20
Solid tumor genomic testing in the UK: challenges and solutions
Alastair Greystoke • 28 Apr 2023
1:51
NHS England: a pilot ctDNA study to track patient responses to novel genomic targets
Alastair Greystoke • 27 Apr 2023
5:59
Deciphering an NGS report in lung cancer
Alastair Greystoke • 24 Jan 2022
3:34
Strategies to improve biomarker testing in the UK
Alastair Greystoke • 24 Jan 2022

Related Videos

3:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat • 19 Apr 2024
2:09
Is there a role for radiotherapy in extensive-stage SCLC?
Clive Peedell • 18 Apr 2024
3:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat • 19 Apr 2024
1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals